Abstract
We studied the survival rates and the prognostic variables that corresponded to death during hospitalization in 312 AIDS CDC group IV patients in São Paulo. Discriminant analysis proved to be a good tool to perform the exploratory data analysis that guided the survival analysis groups. It selected nine variables that were important in the progress of the disease: age, time elapsed from the first manifestations of the disease, gender, infection by helminths, number of risk groups to which the patient belonged, number of infections by fungi, history of transfusion, presence of esophageal candidiasis, and infection byCryptosporidium sp. Although some of these variables may be of limited importance in developed countries, and some variables that we expected to be important were not present in the final discriminant function, we believe these results may guide future research in prognosis of death in hospitalized AIDS patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
World Health Organization and Centers for Disease Control. Statistics from the World Health Organization and Centers for Disease control.AIDS 4(12):1305–1310, 1990.
World Health Organization,World Health Statistics Annuary: Table i, 33–4. Geneve, WHO, 1990.
Veronesi, R., Focaccia, R., Mazza, C., and Weinberg, A., AIDS/SIDA. In (Veronesi, R., ed.),Doenças Infecciosas e Parasitárias. Guanabara-Kogan, São Paulo, 1991.
Ministério da Saúde, Bol. Epidemiol. 3(8), 1990.
Chin, J., and Mann, J.M., The global patterns and prevalence of AIDS and HIV infection.AIDS 2(suppl. 1):S247-S252, 1988.
Veronesi, R., Mazza, C., Ferreira, M., and Lourenço, M., HIV-2 in Brazil.Lancet (2):402, 1987.
Conlon, C., Clinical aspects of HIV infection in developing countries.Brit. Med. Bull. 44(1):101–114, 1988.
Turner, B.J., Kelly, J.V., and Ball, J.K., A severity classification system for AIDS hospitalizations.Med. Care. 27(4):423–437, 1989.
Rothemberg, R., Survival with the acquired immunodeficiency syndrome.New Engl. J. Med. 317(21):2197–1302, 1987.
Lemp, G., Hirozawa, A., Areneta, M., Young, K., and Neri, G., Improved survival for persons with AIDS in San Francisco.Proceedings of the Seventh International Conference on AIDS, 66: Florence, 1991.
Marasca, G., and McEvoy, M. Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom.Br. Med. J. 292:1727–1729.
Longini, I.M., Statistical analysis of the stages of HIV infection using a Markov model.Stat. Med. (8):831–843, 1989.
Araneta, M.R., Survival trends among women with AIDS in San Francisco.Proceedings of the Seventh International Conference on AIDS, 328: Florence, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohno-Machado, L. Prognostic classification for aids patients in Brazil. J Med Syst 17, 163–172 (1993). https://doi.org/10.1007/BF00996941
Issue Date:
DOI: https://doi.org/10.1007/BF00996941